A study has showed that TRPM8 over-expressed in advanced prostate cancer, and TRPM8 promoted cancer cell growth in vitro hypoxia, drug resistance, and in vivo tumorigenicity, with increased HIF-1α expression. The gene discussed is HIF1A; the disease is prostate carcinoma.